Natco Pharma Limited has informed the Exchange about press release dated 25-Jul-2022 titled Approval of its ANDA for Cabazitaxel Intravenous Solution (generic for Jevtana Kit��)……
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
